Without Congressional Action, Telehealth Waivers to Expire March 31
Draft Continuing Resolution released on March 8 includes an extension of the telehealth flexibilities through September 30
Draft Continuing Resolution released on March 8 includes an extension of the telehealth flexibilities through September 30
This factsheet discusses HPV and related cancers, use of the HPV vaccines for both females and males, and insurance coverage and access to the vaccines.
Jules Netherland traveled from her home in the Bronx to the New York state Capitol in Albany several times in the past few years, hoping to persuade the legislature to pass a medical aid in dying bill, allowing terminally ill patients to end their lives with a lethal prescription. She spoke at rallies. With other…
Drug makers sometimes offer copay coupons to lower consumers’ out-of-pocket costs for their brand-name prescriptions, though how private health plans treat those coupons can substantially limit their value to consumers. This issue brief provides an overview of such copay adjustment programs, stakeholder arguments for and against their use, their prevalence, and federal and state efforts…
When coordinators are buried in documentation, scheduling, and data reconciliation, patient engagement is the first thing to go. And when engagement drops, retention drops with it. The post Clinical Operations Burnout Is Undermining Patient Enrollment appeared first on MedCity News.
Experts are split on whether H.R. 1 Medicaid changes in 2027 will roll out gradually or on schedule. The post Could There Be a ‘Soft Opening’ of H.R. 1 Medicaid Changes? appeared first on MedCity News.
Climate change not only impacts patients with respiratory allergies, but it also has potential broad and emerging impacts on patients with food allergies and overall public health. The post The Overlooked Global Warming Cost We Can’t Ignore appeared first on MedCity News.
When the technology changes even slightly, the psychological impact can be detrimental to a person’s health and sometimes, even debilitating. The post Rethinking AI’s Role in Mental Health with GPT-5 appeared first on MedCity News.
Neurovalens’ Modius Spero has become the first FDA-approved neuromodulation device for treating PTSD symptoms. Veterans are set to gain access through the VA this summer. The post FDA Clears First Neurostimulation Device for PTSD appeared first on MedCity News.